Ursprung des Netzwerks ersten Grades von Christopher Wick
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 62 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christopher Wick
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BAXALTA INC | Biotechnology | Director/Board Member Human Resources Officer Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ANHEUSER-BUSCH INBEV SA/NV | Beverages: Alcoholic | Director/Board Member Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | General Counsel Chief Tech/Sci/R&D Officer | |
Wiggin & Dana LLP
 Wiggin & Dana LLP Miscellaneous Commercial ServicesCommercial Services Wiggin & Dana LLP provides legal services. The firm’s client includes publicly traded companies, hospitals and other health care organizations, universities, entrepreneurs and emerging growth companies, real estate developers, financial institutions, museums, and charitable organizations and individuals. The company was founded in 1934 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| ACCELERON PHARMA INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| MONSANTO | Wholesale Distributors | Director/Board Member General Counsel | |
BBI Diagnostics Group 2 Plc
 BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Packaged Software | Chairman Director/Board Member | |
| BENEVOLENTAI | Biotechnology | Chief Executive Officer Director/Board Member | |
| ALERE INC | Medical Specialties | Compliance Officer General Counsel | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Graduate Degree | |
| HOLOGIC, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| The Pennsylvania State University | College/University | Masters Business Admin Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director of Finance/CFO Chairman | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| DUN & BRADSTREET CORP | Data Processing Services | Chairman Director/Board Member | |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Biotechnology | President Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Private Equity Investor | |
| National Standards Authority of Ireland | Chairman | ||
Smith & Nephew NV/SA
 Smith & Nephew NV/SA Medical SpecialtiesHealth Technology Smith & Nephew NV engages in the development of medical technologies. It offers advanced wound management and advanced surgical devices. The company was founded on April 13, 2001 and is headquartered in Zaventem, Belgium. | Medical Specialties | Corporate Officer/Principal | |
Alexion Pharma International Operations Ltd.
 Alexion Pharma International Operations Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Alexion Pharma International Operations Ltd. wholesales drugs, proprietaries and sundries. The company is based in Dublin, Ireland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 41 |
| Vereinigtes Königreich | 5 |
| Schweiz | 3 |
| Belgien | 3 |
| Irland | 3 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Health Services | 4 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 225 |
| Corporate Officer/Principal | 138 |
| Independent Dir/Board Member | 91 |
| Undergraduate Degree | 42 |
| General Counsel | 35 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Felix Baker | 28 |
| Francois Nader | 28 |
| M. Burns | 23 |
| Christopher Coughlin | 23 |
| Paul Friedman | 21 |
| Deborah Dunsire | 20 |
| David Brennan | 19 |
| Andreas Rummelt | 18 |
| Camille Bedrosian | 18 |
| Judith Reinsdorf | 18 |
| Ellen Chiniara | 16 |
| Julie O'Neill | 16 |
| Jacques Suzanne | 15 |
| Paul Clancy | 14 |
| John Orloff | 13 |
- Börse
- Insiders
- Christopher Wick
- Unternehmensverbindungen